173 related articles for article (PubMed ID: 11115699)
1. Mycobacterium bovis bacillus calmette-guérin induces protective immunity against infection by Plasmodium yoelii at blood-stage depending on shifting immunity toward Th1 type and inducing protective IgG2a after the parasite infection.
Matsumoto S; Yukitake H; Kanbara H; Yamada H; Kitamura A; Yamada T
Vaccine; 2000 Nov; 19(7-8):779-87. PubMed ID: 11115699
[TBL] [Abstract][Full Text] [Related]
2. Recombinant Mycobacterium bovis bacillus Calmette-Guérin secreting merozoite surface protein 1 (MSP1) induces protection against rodent malaria parasite infection depending on MSP1-stimulated interferon gamma and parasite-specific antibodies.
Matsumoto S; Yukitake H; Kanbara H; Yamada T
J Exp Med; 1998 Sep; 188(5):845-54. PubMed ID: 9730886
[TBL] [Abstract][Full Text] [Related]
3. Study on protective immunity against infection of Plasmodium yoelii 17XL in DBA/2 mice.
Zheng W; Liu J; Meng DY; Hu XF; Cao YM
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2006 Feb; 24(1):14-8. PubMed ID: 16866134
[TBL] [Abstract][Full Text] [Related]
4. Involvement of CD8+ T cells in protective immunity against murine blood-stage infection with Plasmodium yoelii 17XL strain.
Imai T; Shen J; Chou B; Duan X; Tu L; Tetsutani K; Moriya C; Ishida H; Hamano S; Shimokawa C; Hisaeda H; Himeno K
Eur J Immunol; 2010 Apr; 40(4):1053-61. PubMed ID: 20101613
[TBL] [Abstract][Full Text] [Related]
5. Prolonged Th1-like response generated by a Plasmodium yoelii-specific T cell clone allows complete clearance of infection in reconstituted mice.
Amante FH; Good MF
Parasite Immunol; 1997 Mar; 19(3):111-26. PubMed ID: 9106817
[TBL] [Abstract][Full Text] [Related]
6. Outcome of primary lethal and nonlethal Plasmodium yoelii malaria infection in BALB/c and IFN-γ receptor-deficient mice following chloroquine treatment.
Ishih A; Kawakami C; Todoroki A; Hirai H; Ohori K; Kobayashi F
Parasitol Res; 2013 Feb; 112(2):773-80. PubMed ID: 23180129
[TBL] [Abstract][Full Text] [Related]
7. Interferon-gamma and the induction of protective IgG2a antibodies in non-lethal Plasmodium berghei infections of mice.
Waki S; Uehara S; Kanbe K; Nariuch H; Suzuki M
Parasite Immunol; 1995 Oct; 17(10):503-8. PubMed ID: 8587787
[TBL] [Abstract][Full Text] [Related]
8. Gene gun-based co-immunization of merozoite surface protein-1 cDNA with IL-12 expression plasmid confers protection against lethal Plasmodium yoelii in A/J mice.
Sakai T; Hisaeda H; Nakano Y; Zhang M; Takashima M; Ishii K; Maekawa Y; Matsumoto S; Nitta Y; Miyazaki Ji; Yamamoto S; Himeno K
Vaccine; 2003 Mar; 21(13-14):1432-44. PubMed ID: 12615440
[TBL] [Abstract][Full Text] [Related]
9. Prophylactic treatment of L-Arg improves malaria outcomes by regulating host immune responses during Plasmodium yoelii 17XL infection.
Wang Q; Feng Y; Sun X; Pang W; Fu W; Cao Y
Exp Parasitol; 2018 Dec; 195():1-7. PubMed ID: 30266573
[TBL] [Abstract][Full Text] [Related]
10. Effects of in vivo administration of anti-IL-10 or anti-IFN-gamma monoclonal antibody on the host defense mechanism against Plasmodium yoelii yoelii infection.
Kobayashi F; Ishida H; Matsui T; Tsuji M
J Vet Med Sci; 2000 Jun; 62(6):583-7. PubMed ID: 10907683
[TBL] [Abstract][Full Text] [Related]
11. MAPK phosphotase 5 deficiency contributes to protection against blood-stage Plasmodium yoelii 17XL infection in mice.
Cheng Q; Zhang Q; Xu X; Yin L; Sun L; Lin X; Dong C; Pan W
J Immunol; 2014 Apr; 192(8):3686-96. PubMed ID: 24634491
[TBL] [Abstract][Full Text] [Related]
12. Complete protective immunity induced in mice by immunization with the 19-kilodalton carboxyl-terminal fragment of the merozoite surface protein-1 (MSP1[19]) of Plasmodium yoelii expressed in Saccharomyces cerevisiae: correlation of protection with antigen-specific antibody titer, but not with effector CD4+ T cells.
Hirunpetcharat C; Tian JH; Kaslow DC; van Rooijen N; Kumar S; Berzofsky JA; Miller LH; Good MF
J Immunol; 1997 Oct; 159(7):3400-11. PubMed ID: 9317139
[TBL] [Abstract][Full Text] [Related]
13. Suppression of lethal Plasmodium yoelii malaria following protective immunization requires antibody-, IL-4-, and IFN-gamma-dependent responses induced by vaccination and/or challenge infection.
Petritus PM; Burns JM
J Immunol; 2008 Jan; 180(1):444-53. PubMed ID: 18097046
[TBL] [Abstract][Full Text] [Related]
14. Induction of long-lasting immunity to Plasmodium yoelii malaria with whole blood-stage antigens and copolymer adjuvants.
Hunter RL; Kidd MR; Olsen MR; Patterson PS; Lal AA
J Immunol; 1995 Feb; 154(4):1762-9. PubMed ID: 7836760
[TBL] [Abstract][Full Text] [Related]
15. Plasmodium yoelii blood-stage antigens newly identified by immunoaffinity using purified IgG antibodies from malaria-resistant mice.
Kamali AN; Marín-García P; Azcárate IG; Diez A; Puyet A; Bautista JM
Immunobiology; 2012 Aug; 217(8):823-30. PubMed ID: 22658767
[TBL] [Abstract][Full Text] [Related]
16. IL-12 is required for antibody-mediated protective immunity against blood-stage Plasmodium chabaudi AS malaria infection in mice.
Su Z; Stevenson MM
J Immunol; 2002 Feb; 168(3):1348-55. PubMed ID: 11801675
[TBL] [Abstract][Full Text] [Related]
17. Listeria monocytogenes inoculation protects mice against blood-stage Plasmodium yoelii infection.
Qi Z; Han X; Zhang Y; Wang J; Cao YM
Tohoku J Exp Med; 2013 Feb; 229(2):87-96. PubMed ID: 23303295
[TBL] [Abstract][Full Text] [Related]
18. The generation and evaluation of two panels of epitope-matched mouse IgG1, IgG2a, IgG2b and IgG3 antibodies specific for Plasmodium falciparum and Plasmodium yoelii merozoite surface protein 1-19 (MSP1(19)).
Adame-Gallegos JR; Shi J; McIntosh RS; Pleass RJ
Exp Parasitol; 2012 Apr; 130(4):384-93. PubMed ID: 22343045
[TBL] [Abstract][Full Text] [Related]
19. Fc receptors are not required for antibody-mediated protection against lethal malaria challenge in a mouse model.
Rotman HL; Daly TM; Clynes R; Long CA
J Immunol; 1998 Aug; 161(4):1908-12. PubMed ID: 9712060
[TBL] [Abstract][Full Text] [Related]
20. Long-lasting protective immunity against rodent malaria parasite infection at the blood stage by recombinant BCG secreting merozoite surface protein-1.
Matsumoto S; Yukitake H; Kanbara H; Yamada T
Vaccine; 1999 Dec; 18(9-10):832-4. PubMed ID: 10580196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
